Search

Your search keyword '"Fernandez-Fernandez B"' showing total 87 results

Search Constraints

Start Over You searched for: Author "Fernandez-Fernandez B" Remove constraint Author: "Fernandez-Fernandez B"
87 results on '"Fernandez-Fernandez B"'

Search Results

1. CKD: The burden of disease invisible to research funders

2. Large expert-curated database for benchmarking document similarity detection in biomedical literature search

3. GLP-1 Receptor Agonists and Diabetic Kidney Disease: A Call of Attention to Nephrologists

4. Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trial

5. Exploring Sodium Glucose Co-Transporter-2 (SGLT2) Inhibitors for Organ Protection in COVID-19

6. Large expert-curated database for benchmarking document similarity detection in biomedical literature search

8. Large expert-curated database for benchmarking document similarity detection in biomedical literature search

9. Research update for articles published in EJCI in 2016

10. Increasing serum calcium levels and recent return from transplantation as clues to the tuberculous nature of refractory peritoneal dialysis peritonitis

14. Juxtaglomerular apparatus hyperplasia under dual angiotensin blockade. A footprint of adequate RAS inhibition or a concern for renal fibrosis?

15. Optimizing the timing of nephrology referral for patients with diabetic kidney disease

16. Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation and Study of Diabetic Nephropathy with Atrasentan: what was learned about the treatment of diabetic kidney disease with canagliflozin and atrasentan?

17. Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation and Study of Diabetic Nephropathy with Atrasentan : what was learned about the treatment of diabetic kidney disease with canagliflozin and atrasentan?

18. Large expert-curated database for benchmarking document similarity detection in biomedical literature search

19. Research update for articles published in EJCI in 2016

20. Primary aldosteronism prevalence enhanced by strict adherence to 2016 Endocrine Society guidelines: insights from an endocrine hypertension unit.

21. Prognostic and therapeutic monitoring value of plasma and urinary cytokine profile in primary membranous nephropathy: the STARMEN trial cohort.

22. Systems Biology and Novel Biomarkers for the Early Detection of Diabetic Kidney Disease.

23. Sex disparities in mortality and cardiovascular outcomes in chronic kidney disease.

24. STING1 deficiency ameliorates immune-mediated crescentic glomerulonephritis in mice.

25. SGLT2i for evidence-based cardiorenal protection in diabetic and non-diabetic chronic kidney disease: a comprehensive review by EURECA-m and ERBP working groups of ERA.

27. Gender-specific risk factors and outcomes of hyperkalemia in CKD patients: smoking as a driver of hyperkalemia in men.

28. Mineralocorticoid receptor antagonist use in chronic kidney disease with type 2 diabetes: a clinical practice document by the European Renal Best Practice (ERBP) board of the European Renal Association (ERA).

30. Targeting inflammation to treat diabetic kidney disease: the road to 2030.

31. Sodium zirconium cyclosilicate and metabolic acidosis: Potential mechanisms and clinical consequences.

32. Tirzepatide and prevention of chronic kidney disease.

33. Repurposing drugs for highly prevalent diseases: pentoxifylline, an old drug and a new opportunity for diabetic kidney disease.

35. Phosphate, Microbiota and CKD.

36. SGLT2 inhibitors for non-diabetic kidney disease: drugs to treat CKD that also improve glycaemia.

37. Optimizing the timing of nephrology referral for patients with diabetic kidney disease.

38. Epigenetic Modifiers as Potential Therapeutic Targets in Diabetic Kidney Disease.

39. Gender, Albuminuria and Chronic Kidney Disease Progression in Treated Diabetic Kidney Disease.

40. SGLT2i and postglomerular vasodilation.

41. MAP3K kinases and kidney injury.

42. Klotho, the elusive kidney-derived anti-ageing factor.

43. The chaos of hypertension guidelines for chronic kidney disease patients.

44. Clarifying the concept of chronic kidney disease for non-nephrologists.

46. Advances in understanding the role of angiotensin-regulated proteins in kidney diseases.

47. Albumin downregulates Klotho in tubular cells.

48. Research update for articles published in EJCI in 2016.

49. Meso-American nephropathy: what we have learned about the potential genetic influence on chronic kidney disease development.

50. Impact of Altered Intestinal Microbiota on Chronic Kidney Disease Progression.

Catalog

Books, media, physical & digital resources